SC 13G/A | 2024-02-14 | Redmile Group, LLC | PLIANT THERAPEUTICS, INC. | 2,696,648 | 4.5% | EDGAR |
SC 13G/A | 2024-02-14 | Deep Track Capital, LP | PLIANT THERAPEUTICS, INC. | 5,750,000 | 9.6% | EDGAR |
SC 13G/A | 2024-02-14 | Third Rock Ventures III, L.P. | PLIANT THERAPEUTICS, INC. | 339,160 | 0.6% | EDGAR |
SC 13G | 2024-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | PLIANT THERAPEUTICS, INC. | 3,788,116 | 6.3% | EDGAR |
SC 13G | 2024-02-14 | Blue Owl Capital Holdings LP | PLIANT THERAPEUTICS, INC. | 3,004,199 | 5.0% | EDGAR |
SC 13G | 2024-02-14 | First Light Asset Management, LLC | PLIANT THERAPEUTICS, INC. | 3,634,510 | 6.1% | EDGAR |
SC 13G | 2024-02-13 | VANGUARD GROUP INC | PLIANT THERAPEUTICS, INC. | 3,065,869 | 5.1% | EDGAR |
SC 13G/A | 2024-02-09 | FMR LLC | PLIANT THERAPEUTICS, INC. | 3,963,417 | 6.6% | EDGAR |
SC 13G | 2024-02-08 | Laurion Capital Management LP | PLIANT THERAPEUTICS, INC. | 3,583,567 | 6.0% | EDGAR |
SC 13G | 2024-01-25 | BlackRock Inc. | PLIANT THERAPEUTICS, INC. | 4,801,517 | 8.0% | EDGAR |
SC 13G | 2023-03-20 | Deep Track Capital, LP | PLIANT THERAPEUTICS, INC. | 3,104,507 | 5.3% | EDGAR |
SC 13G/A | 2023-02-14 | Redmile Group, LLC | PLIANT THERAPEUTICS, INC. | 3,878,599 | 8.0% | EDGAR |
SC 13G/A | 2023-02-14 | Third Rock Ventures III, L.P. | PLIANT THERAPEUTICS, INC. | 1,839,160 | 3.8% | EDGAR |
SC 13G/A | 2023-02-13 | CHI Advisors LLC | PLIANT THERAPEUTICS, INC. | 3,199,892 | 6.6% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | PLIANT THERAPEUTICS, INC. | 4,393,231 | 9.0% | EDGAR |
SC 13G/A | 2022-08-31 | Novartis Institutes for BioMedical Research, Inc. | PLIANT THERAPEUTICS, INC. | 2,153,526 | 4.4% | EDGAR |
SC 13G/A | 2022-08-10 | FMR LLC | PLIANT THERAPEUTICS, INC. | 6,145,418 | 12.6% | EDGAR |
SC 13G/A | 2022-06-10 | FMR LLC | PLIANT THERAPEUTICS, INC. | 3,472,571 | 9.6% | EDGAR |
SC 13G/A | 2022-02-14 | Redmile Group, LLC | PLIANT THERAPEUTICS, INC. | 3,083,501 | 8.6% | EDGAR |
SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | PLIANT THERAPEUTICS, INC. | 42,499 | 0.1% | EDGAR |